Centrafarm Services B.V. Eurogenerics NV/SA Lamp San Prospero S.p.A Jelfa Pharmaceutical Company S.A. Sofarimex Chemical and Pharmaceutical Industry S.A. STADA Arzneimittel AG

It is used in the treatment of mild reflux disease and its symptoms (such as heartburn, pain upon swallowing, or regurgitation of gastric contents), in the treatment and prevention of recurrence of esophagitis, and in the prevention of gastric and duodenal ulcers in individuals taking long-term pain medication (NSAIDs).

Dosage form: tablets, enteric-coated

ATC: A02BC02

The medicine is used in the treatment of gastric and duodenal ulcer disease (including for the eradication of Helicobacter pylori bacteria), in the treatment of reflux esophagitis, and in conditions related to excessive hydrochloric acid secretion in the stomach.

Dosage form: tablets, enteric-coated

ATC: A02BC02